At the time of writing, PMV Pharmaceuticals Inc [PMVP] stock is trading at $1.60, down -6.43%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
PMV Pharmaceuticals Inc [NASDAQ: PMVP] stock has seen the most recent analyst activity on May 13, 2024, when Craig Hallum initiated its Buy rating and assigned the stock a price target of $6. Previously, Jefferies started tracking the stock with Buy rating on April 12, 2024, and set its price target to $5. On December 27, 2023, Ladenburg Thalmann initiated with a Buy rating and assigned a price target of $7 on the stock. Oppenheimer upgraded its rating to a Outperform but stick to its price target of $30 on March 02, 2022. Goldman upgraded its rating to a Buy and raised its price target to $43 on September 22, 2021. In a note dated August 02, 2021, Guggenheim initiated an Buy rating and provided a target price of $56 on this stock.
For the past year, the stock price of PMV Pharmaceuticals Inc fluctuated between $1.17 and $3.47. Currently, Wall Street analysts expect the stock to reach $24.75 within the next 12 months. PMV Pharmaceuticals Inc [NASDAQ: PMVP] shares were valued at $1.60 at the most recent close of the market. An investor can expect a potential return of 1446.87% based on the average PMVP price forecast.
Analyzing the PMVP fundamentals
Gross Profit Margin for this corporation currently stands at 0.1% with Operating Profit Margin at -47.54%, Pretax Profit Margin comes in at -40.21%, and Net Profit Margin reading is -30.21%. To continue investigating profitability, this company’s Return on Assets is posted at -0.21, Equity is -0.22 and Total Capital is -0.34. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.4933 points at the first support level, and at 1.3867 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.7633, and for the 2nd resistance point, it is at 1.9267.
Ratios To Look Out For
It is important to note that PMV Pharmaceuticals Inc [NASDAQ:PMVP] has a current ratio of 19.22. As well, the Quick Ratio is 19.22, while the Cash Ratio is 4.33.
Transactions by insiders
Recent insider trading involved Jalota Deepika, Chief Development Officer, that happened on Sep 11 ’24 when 7218.0 shares were sold. Chief Financial Officer, Carulli Michael completed a deal on Sep 11 ’24 to sell 2891.0 shares. Meanwhile, 10% Owner ORBIMED ADVISORS LLC sold 87786.0 shares on Nov 22 ’23.
